2024 – Next generation gene therapy vectors

Home2024

August 28, 2024

rAAVen and Cellevate Partner on AAV Library Testing

Together w

rAAVen Welcomes Yuriy Pomeshchik as Director of In Vitro

rAAVen The

rAAVen to Present at #ASGCT2024 and Myrtelle Symposium

rAAVen The

rAAVen Partners with Prevail to Advance AAVs for Neurological Disorders

rAAVen The

rAAVen Appoints Magnus Henriks as Chief Executive Officer

rAAVen The

January 18, 2024

rAAVen and Myrtelle Expand Partnership for Capsid Validation

rAAVen The